Andrea Saia - LivaNova PLC Non-Executive Independent Director
| LIVN Stock | USD 55.75 0.42 0.75% |
Director
Ms. Andrea L. Saia is Independent Director of the Company. Ms. Saia is an accomplished global business leader having held executive positions in the medical devices and consumer products industries with multinational companies including Novartis, Unilever, Revlon and Procter Gamble. From 2008 until 2011, Ms. Saia served as CEO of Ciba Vision, a Novartis company. From 2011 to 2012, she served as Global Head of Alcons Vision Care Business Unit, another Novartis company. Additionally, she served as Chief Operating Officer, Chief Marketing Officer, and President Europe, Middle East and Africa of Ciba Vision since 2016.
| Age | 60 |
| Tenure | 8 years |
| Professional Marks | MBA |
| Address | 20 Eastbourne Terrace, London, United Kingdom, W2 6LG |
| Phone | 44 20 3325 0660 |
| Web | https://www.livanova.com |
LivaNova PLC Management Efficiency
The company has return on total asset (ROA) of 0.0176 % which means that it generated a profit of $0.0176 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0141 %, meaning that it created $0.0141 on every $100 dollars invested by stockholders. LivaNova PLC's management efficiency ratios could be used to measure how well LivaNova PLC manages its routine affairs as well as how well it operates its assets and liabilities. As of the 30th of April 2024, Return On Tangible Assets is likely to grow to 0.01. Also, Return On Capital Employed is likely to grow to 0.05. At this time, LivaNova PLC's Intangible Assets are very stable compared to the past year. As of the 30th of April 2024, Net Tangible Assets is likely to grow to about 116.1 M, while Deferred Long Term Asset Charges is likely to drop about 4.8 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| William Grieco | Acadia Healthcare | 64 | |
| Chris Gordon | Acadia Healthcare | 44 | |
| Annie Lamont | HCA Holdings | 60 | |
| Vicky Gregg | Acadia Healthcare | 63 | |
| William Petrie | Acadia Healthcare | 71 | |
| Meg Crofton | HCA Holdings | 67 | |
| Geoffrey Meyers | HCA Holdings | 73 | |
| Christopher Gordon | Acadia Healthcare | 44 | |
| Wade Miquelon | Acadia Healthcare | 53 | |
| Ann Lamont | HCA Holdings | 58 | |
| Jay Light | HCA Holdings | 74 | |
| Michael Michelson | HCA Holdings | 69 | |
| William Frist | HCA Holdings | 51 | |
| Charles Holliday | HCA Holdings | 73 | |
| Michael Gaynor | Novo Integrated Sciences | 49 | |
| Kyle Lattner | Acadia Healthcare | 29 | |
| NancyAnn DeParle | HCA Holdings | 64 | |
| Hartley Rogers | Acadia Healthcare | 56 | |
| Robert Dennis | HCA Holdings | 67 | |
| John Rowe | HCA Holdings | 72 | |
| EPerot Bissell | Acadia Healthcare | 58 | |
Management Performance
| Return On Equity | 0.0141 | ||||
| Return On Asset | 0.0176 |
LivaNova PLC Leadership Team
Elected by the shareholders, the LivaNova PLC's board of directors comprises two types of representatives: LivaNova PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of LivaNova. The board's role is to monitor LivaNova PLC's management team and ensure that shareholders' interests are well served. LivaNova PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, LivaNova PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pritpal Shinmar, Senior Vice President - Global Market Access | ||
| Daniel Moore, Non-Executive Chairman of the Board | ||
| Stephanie Bolton, President Epilepsy | ||
| Alfred Novak, Independent Director | ||
| Arthur Rosenthal, Independent Director | ||
| Matthew III, Senior IT | ||
| Jacques Gutedel, President - Intercontinental | ||
| Deanna Wilke, Vice Communications | ||
| John Webb, Vice Epilepsy | ||
| Keyna Skeffington, Senior Vice President General Counsel | ||
| Francesco Bianchi, Independent Director | ||
| Demetrio Mauro, Chief Integration Officer | ||
| Sharon OKane, Independent Director | ||
| Vivid Sehgal, CFO | ||
| Hugh Morrison, Independent Director | ||
| Marco Dolci, Pres Unit | ||
| Lindsey Little, Director Relations | ||
| Damien McDonald, CEO Director | ||
| William Kozy, Chairman CEO | ||
| Brian Sheridan, Senior Vice President General Counsel, Company Secretary | ||
| David Wise, Chief Admin. Officer, Sr. VP and Secretary | ||
| AndreMichel Ballester, CEO, Executive Director | ||
| Andrea Saia, Non-Executive Independent Director | ||
| Badri Amurthur, Chief Officer | ||
| Michel Darnaud, President - Cardiac Surgery | ||
| Piero Vecchi, Vice President Controller | ||
| Trui Hebbelinck, Chief Human Resource Officer | ||
| Rohan Hoare, COO | ||
| Edward Andrle, Senior Vice President - Strategy & Business Development | ||
| Michael Hutchinson, Chief VP | ||
| Douglas Manko, Chief Accounting Officer | ||
| Ryan Miller, President Support | ||
| Stefano Gianotti, Independent Director | ||
| Thad Huston, CFO | ||
| Alex Shvartsburg, Chief Officer | ||
| Karen King, Vice President - Investor Relations and Corporate Communications | ||
| Bryan Olin, Senior Neuromodulation | ||
| Vladimir Makatsaria, CEO Director | ||
| Stefano Lullo, President - Cardiac Rhythm Management | ||
| Jonathan Walker, VP Segment |
LivaNova Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is LivaNova PLC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0141 | ||||
| Return On Asset | 0.0176 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 3.4 B | ||||
| Shares Outstanding | 53.96 M | ||||
| Shares Owned By Insiders | 0.50 % | ||||
| Shares Owned By Institutions | 99.50 % | ||||
| Number Of Shares Shorted | 3.09 M | ||||
| Price To Earning | 78.67 X |
LivaNova PLC Investors Sentiment
The influence of LivaNova PLC's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in LivaNova. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to LivaNova PLC's public news can be used to forecast risks associated with an investment in LivaNova. The trend in average sentiment can be used to explain how an investor holding LivaNova can time the market purely based on public headlines and social activities around LivaNova PLC. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
LivaNova PLC's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for LivaNova PLC's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average LivaNova PLC's news discussions. The higher the estimated score, the more favorable is the investor's outlook on LivaNova PLC.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards LivaNova PLC in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, LivaNova PLC's short interest history, or implied volatility extrapolated from LivaNova PLC options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LivaNova PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. To learn how to invest in LivaNova Stock, please use our How to Invest in LivaNova PLC guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for LivaNova Stock analysis
When running LivaNova PLC's price analysis, check to measure LivaNova PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LivaNova PLC is operating at the current time. Most of LivaNova PLC's value examination focuses on studying past and present price action to predict the probability of LivaNova PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LivaNova PLC's price. Additionally, you may evaluate how the addition of LivaNova PLC to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is LivaNova PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LivaNova PLC. If investors know LivaNova will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LivaNova PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 9.026 | Earnings Share 0.32 | Revenue Per Share 21.386 | Quarterly Revenue Growth 0.128 | Return On Assets 0.0176 |
The market value of LivaNova PLC is measured differently than its book value, which is the value of LivaNova that is recorded on the company's balance sheet. Investors also form their own opinion of LivaNova PLC's value that differs from its market value or its book value, called intrinsic value, which is LivaNova PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LivaNova PLC's market value can be influenced by many factors that don't directly affect LivaNova PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LivaNova PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if LivaNova PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LivaNova PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.